30 Day Trial
ORTHOKNOW logo

ORTHOKNOW content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Quarterly Review

4Q13/2013 Revenue: Tornier

4Q13 revenue: $83.4MM, +4% (U.S. $47.8MM, +4%; ex-U.S. $35.5MM, +5%)

Total Extremities $68.1MM, +5%

  • Upper $48.2MM, +5%
  • Lower $16.2MM, +10%
  • Sports Med/Biologics $3.7MM, -12%

Large Joints/Other $15.3MM, +3%

 

  • Latitude EV elbow prosthesis supported elbow product growth of 30%+
  • Sports Med/Biologics affected by decline in anchors
  • Completed Phase I of U.S. salesforce transition, direct sales reps now cover ~55% of U.S. revenue

 

2013 revenue: $311.0MM, +11% (U.S. $182.1MM, +16%; ex-U.S. 128.8MM, +7%)

Total Extremities $257.9MM, +14%

  • Upper $184.4MM, +5%
  • Lower $58.7MM, +72%
  • Sports Med/Biologics $14.7MM, -5%

Large Joints/Other $53.0MM, -2%

 

  • >150 physicians trained/using Aequalis Ascend Flex convertible shoulder; product regained some customers lost to competitor systems
  • Threaded baseplate for use with Flex humeral stem in limited launch, to debut at AAOS
  • CannuLink and CannuLink Plus hammertoe correction showing “significant quarter over quarter sequential growth”
  • Currently 400 U.S. sales reps, of which ~145 are direct; will add 15-20 new direct reps to support the split of upper and lower extremity channels

 

2014 forecast:

  • Revenue range $302MM-$317MM
  • Extremities range $252.6MM-$265.5MM